Accessibility Statement

We are committed to providing a website that is accessible to the widest possible audience. To do so, we are actively working with consultants to update the website by increasing its accessibility and usability by persons who use assistive technologies such as automated tools, keyboard-only navigation, and screen readers.

We are working to have the website conform to the relevant standards of the Section 508 Web Accessibility Standards developed by the United States Access Board, as well as the World Wide Web Consortium's (W3C) Web Content Accessibility Guidelines 2.1. These standards and guidelines explain how to make web content more accessible for people with disabilities. We believe that conformance with these standards and guidelines will help make the website more user friendly for all people.

Our efforts are ongoing. While we strive to have the website adhere to these guidelines and standards, it is not always possible to do so in all areas of the website. If, at any time, you have specific questions or concerns about the accessibility of any particular webpage, please contact WebsiteAccess@tenethealth.com so that we may be of assistance.

Thank you. We hope you enjoy using our website.

Skip to Main Content

MetroWest Medical Center Institutional Review Board (MWMCIRB)

The MetroWest Medical Center Institutional Review Board (IRB) is duly constituted (fulfilling FDA requirements for diversity), to allow only those IRB members who are independent of the investigator and the sponsor of the trial to vote on the trial, have written procedures for initial and continuing review of clinical trials, prepare written minutes of convened meetings, and retain records pertaining to the review and approval process; all in compliance with requirements defined in 21 CFR (Code of Federal Regulations) Parts 50, 56 and 312.

Our Board is comprised of highly qualified members with significant experience and knowledge in the ethical, scientific and legal aspects of clinical trials. Click here to view our IRB Roster.

Our priority is to ensure the safety of human subjects in clinical trials, and we are committed to an ethical and thorough review process.

If you need further information, please feel free to call 508-383-1671/508-383-8786 or contact us by email at MWMCIRB@mwmc.com.

Statement of Compliance

Name of IRB: MetroWest Medical Center
IRB Address: 115 Lincoln Street, Framingham, MA 01702
FWA#: 00003242 / FWA Expiration Date: 08/29/2023
IORG: 0002308 / IORG Expiration Date: 06/10/2023

The MetroWest Medical Center Institutional Review Board (IRB) is duly constituted (fulfilling FDA requirements for diversity), allow only those IRB members who are independent of the investigator and the sponsor of the trial to vote on the trial, have written procedures for initial and continuing review of clinical trials, prepare written minutes of convened meetings, and retain records pertaining to the review and approval process; all in compliance with requirements defined in 21 CFR (Code of Federal Regulations) Parts 50, 56 and 312.

The MetroWest Medical Center IRB have met new Institutional Review Board Registration Requirements published in the Federal Register on January 15, 2009 (74 FR 2399 and 74 FR 2358). The new IRB registration requirements became effective July 14, 2009.

The Federal Wide Assurance (FWA) through MetroWest Medical Center delegates the IRB Chair as sole authority to determine what is or isn’t research. Investigators are not permitted to make an exempt determination.

No medical records or patient materials can be reviewed for any research purposes without an exemption letter from the MWMCIRB.

IRB